Table 4.

Univariate linear regression analysis of serum NAMPT and erythrocyte membrane fatty acids with CAP and body fat mass

	Men (n = 32)				Women (n = 30)				Total (N = 62)
	body fat mass		CAP		body fat mass		CAP		body fat mass		CAP
	β	p	β	p	β	p	β	p	β	p	β	p
Serum NAMPT	0.20	0.27	0.33	0.07	0.075	0.69	−0.01	0.61	0.10	0.45	0.10	0.401
DNL index	−0.02	0.91	0.09	0.66	−0.46	0.02	0.26	0.21	−0.11	0.45	0.17	0.23
Palmitic acid	−0.03	0.88	0.26	0.16	0.10	0.64	0.31	0.13	0.17	0.22	0.33	0.01
Age	−0.014	0.94	0.10	0.58	−0.012	0.95	0.32	0.09	0.25	0.05	0.30	0.018
BMI	0.80	0.00	0.30	0.09	0.60	0.00	0.20	0.28	0.67	0.00	0.34	0.007
HOMA	0.48	0.005	0.04	0.04	0.12	0.54	−0.06	0.76	0.24	0.06	0.19	0.126
Dietary CHO	−0.47	0.008	−0.08	0.69	−0.17	0.432	0.21	0.33	−0.41	0.002	−0.05	0.717
Dietary PRO	−0.10	0.61	−0.1	0.59	−0.11	0.60	−0.22	0.30	−0.25	0.07	−0.23	0.095
Physical activity	−0.45	0.01	−0.06	0.77	−0.10	0.63	0.20	0.31	−0.42	0.001	−0.09	0.50

β, β coefficient; BMI, body mass index; CAP, controlled attenuation parameter; CHO, carbohydrate; DNL, de novo lipogenesis; HOMA, homeostasis model assessment; NAMPT, nicotinamide phosphoribosyltransferas; PRO, protein.